Financial Performance - The company's revenue for Q1 2024 was CNY 152,527,488.90, representing a 0.86% increase compared to CNY 151,231,759.11 in the same period last year[5] - Net profit attributable to shareholders increased by 30.30% to CNY 27,443,957.16 from CNY 21,062,048.07 year-on-year[5] - Basic and diluted earnings per share rose by 25.00% to CNY 0.20, compared to CNY 0.16 in the same period last year[5] - Net profit for Q1 2024 reached CNY 27,602,496.15, up from CNY 21,139,197.68 in the same period last year, indicating a growth of approximately 30.5%[26] - The total comprehensive income for the first quarter of 2024 was CNY 26,899,074.67, an increase from CNY 20,853,145.93 in the same period last year, representing a growth of approximately 28.9%[27] Cash Flow - The net cash flow from operating activities surged by 187.38% to CNY 58,382,114.91, up from CNY 20,315,499.86 in the previous year[5] - Cash inflows from operating activities totaled CNY 189,432,504.99, up from CNY 161,812,321.26, marking an increase of about 17.1%[28] - The net cash flow from investment activities decreased to CNY 12,709,583.43 from CNY 43,289,082.82, a decline of approximately 70.7%[30] - The net cash flow from financing activities was negative at CNY -69,953,219.12, compared to a positive CNY 52,538,800.01 in the previous year[31] - The company reported a total cash outflow from operating activities of CNY 131,050,390.08, which is lower than the previous year's CNY 141,496,821.40, indicating a decrease of approximately 7.5%[30] Assets and Liabilities - Total assets decreased by 1.69% to CNY 1,329,739,913.87 from CNY 1,352,557,543.80 at the end of the previous year[5] - Current assets totaled CNY 886,294,141.88, down from CNY 970,807,262.05, representing a decline of approximately 8.7%[20] - The total liabilities decreased to CNY 254,410,038.44 from CNY 293,777,311.55, a reduction of approximately 13.4%[22] - The company's cash and cash equivalents slightly decreased to CNY 276,255,408.14 from CNY 276,380,780.76, indicating a stable liquidity position[20] Investments and Expenses - Investment income surged by 265.52% to CNY 619,034.47, primarily from the maturity of trading financial assets[10] - Research and development expenses increased to CNY 16,526,876.04 from CNY 15,088,487.17, reflecting a commitment to innovation[25] - Sales expenses increased by 45.59% to CNY 13,436,920.27, driven by higher personnel and marketing costs[10] Shareholder Information - Total number of common shareholders at the end of the reporting period is 20,340[12] - Major shareholder Yuan Jianmin holds 52.80% of shares, totaling 72,000,000 shares[12] - The company has 5% or more shareholders, including Yuan Jianmin and Che Haixia, with significant holdings[13] - The company has established relationships among major shareholders, indicating potential coordinated actions[13] Share Repurchase and Incentive Plans - The company plans to repurchase shares with a total amount not less than RMB 40 million and not exceeding RMB 80 million, with a maximum price of RMB 29 per share[16] - The repurchase period is set for up to 12 months from the board's approval date[17] - The company has completed the initial grant registration of the 2022 restricted stock incentive plan, granting 3,021,500 shares at a price of RMB 18.16 per share[15] - The company has not yet completed the share repurchase process as of the report date[17] Certifications and Product Development - The company received EU MDR certification for its electronic thermometer, electronic blood pressure monitor, and pulse oximeter products[14] - The company reported a significant increase in goodwill by 172.20%, reaching CNY 20,755,049.91 due to the acquisition of a subsidiary's asset group[9] - The company reported a significant increase in inventory, which rose to CNY 278,838,080.30 from CNY 268,765,799.42, an increase of about 3.99%[20]

深圳市华盛昌科技实业股份有限公司 内部控制审计报告 大华内字[2024]0011000151 号 大 华 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) Da Hua Certified Public Accountants (Special General Partnership) 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn）"进行查理 报告编码:京24XJEN 深圳市华盛昌科技实业股份有限公司 内部控制审计报告 （截止 2023 年 12 月 31 日 ） 目 页 次 一、 1-2 内 部 控 制 审 计 报 告 大华内字[2024]0011000151 号 深圳市华盛昌科技实业股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相 关要求,我们审计了深圳市华盛昌科技实业股份有限公司(以下简称 华盛昌公司）2023年12月31日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企 业内部控制评价指引》的规定,建立健全和有效实施内部控制,并评 价其有效性是 ...

证券代码：002980 证券简称：华盛昌 公告编号：2024-035 深圳市华盛昌科技实业股份有限公司 关于 2023 年度利润分配预案的公告 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 深圳市华盛昌科技实业股份有限公司（以下简称"公司"）于 2024 年 4 月 18 日召开第三届董事会 2024 年第五次会议、第三届监事会 2024 年第二次会议， 审议通过了公司《2023 年度利润分配预案》，前述议案尚需提交股东大会审议， 具体情况如下： 分配方案公布后至实施前，公司总股本由于增发新股、股权激励行权、可转 债转股、公司回购股份等原因发生变动的，以未来实施利润分配方案时股权登记 日的可参与利润分配的股本为基数，按照分配比例不变的原则对分配金额进行调 整。 本次利润分配预案符合相关法律法规、《公司章程》规定的利润分配政策及 股东回报的要求，公司的现金分红水平与所处行业上市公司平均水平不存在重大 差异，与公司业绩成长性相匹配，上述利润分配预案具备合法性、合规性、合理 性。 一、2023 年度利润分配预案基本情况 1、董事会审议情况 公司第三届董事会 2 ...

证券代码：002980 证券简称：华盛昌 公告编号：2024-037 深圳市华盛昌科技实业股份有限公司 关于公司会计政策变更的公告 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 深圳市华盛昌科技实业股份有限公司（以下简称"公司"）于2024年4月18日 召开第三届董事会2024年第五次会议、第三届监事会2024年第二次会议，审议通 过了《关于公司会计政策变更的议案》。财政部于2023年10月25日公布了《企业 会计准则解释第17号》（财会【2023】21号）（以下简称"解释第17号"），公司根 据解释第17号的要求，对原采用的相关会计政策进行相应变更，本次变更不会对 公司财务状况、经营成果和现金流量产生重大影响，具体情况如下： 一、本次会计政策变更概述 （一）会计政策变更日期及原因 财政部于2023年10月25日公布了解释第17号，"关于流动负债与非流动负债 的划分"、"关于供应商融资安排的披露"和"关于售后租回交易的会计处理"内 容自2024年1月1日起施行。 由于上述会计准则的变化，公司将对原采用的相关会计政策进行变更，并按 以上文件规定的起始日开始 ...

根据《上市公司独立董事管理办法》、《深圳证券交易所上市公司自律监管 指引第 1 号——主板上市公司规范运作》、《深圳市华盛昌科技实业股份有限公 司章程》（以下简称"《公司章程》"）及《深圳市华盛昌科技实业股份有限公 司独立董事工作细则》等相关规定，并结合独立董事出具的《独立董事关于独立 性自查情况的报告》，深圳市华盛昌科技实业股份有限公司（以下简称"公司"） 董事会就公司在任独立董事庄任艳女士、浦洪先生、李学金先生的独立性情况进 行评估并出具如下专项意见： 深圳市华盛昌科技实业股份有限公司 董事会对独立董事独立性自查情况的专项报告 经核查独立董事庄任艳女士、浦洪先生、李学金先的任职经历以及签署的相 关自查文件等内容，公司董事会认为上述人员未在公司担任独立董事以外的任何 职务，也未在公司主要股东担任任何职务，与公司以及主要股东之间不存在利害 关系或其他可能妨碍其进行独立客观判断的关系，不存在其他影响独立董事独立 性的情况，因此，公司独立董事符合《上市公司独立董事管理办法》、《深圳证 券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等相关法律 法规及《公司章程》中对独立董事独立性的相关要求。 深圳 ...

证券代码：002980 证券简称：华盛昌 公告编号：2024-039 深圳市华盛昌科技实业股份有限公司 关于开展外汇套期保值业务的公告 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1、业务基本情况：为防范和减轻汇率波动对公司经营业绩的影响，公司及 下属子公司拟与银行等金融机构开展不超过等值 2,000 万美元额度的外汇套期 保值业务，包括远期结售汇、外汇掉期、外汇互换、外汇期货、外汇期权及其他 外汇衍生产品业务。 2、已经履行的审议程序：本事项已经公司第三届董事会 2024 年第五次会议 及第三届监事会 2024 年第二次会议审议通过，无需提交公司股东大会审议。 3、风险提示：在外汇套期保值业务开展过程中存在汇率波动、内部控制、 交易违约及预测风险，敬请广大投资者注意投资风险。 深圳市华盛昌科技实业股份有限公司（以下简称"公司"）于 2024 年 4 月 18 日召开第三届董事会 2024 年第五次会议、第三届监事会 2024 年第二次会议，审 议通过了《关于开展外汇套期保值业务的议案》。公司及下属子公司使用总额不 超过等值 2,000 ...

深圳市华盛昌科技实业股份有限公司 募集资金存放与使用情况鉴证报告 大华核字[2024]0011002839 号 大 华 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) Da Hua Certified Public Accountants (Special General Partnership) 您可使用手机"扫一扫"或进入"注册会计师行业统一监管用具有效业许可的会计师事务所出身 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn）"进行查验 报告编码:京24QZOGI 深圳市华盛昌科技实业股份有限公司 募集资金存放与使用情况鉴证报告 目 页 次 募集资金存放与使用情况鉴证报告 1-2 11 深圳市华盛昌科技实业股份有限公司 2023 年 1-7 度募集资金存放与使用情况的专项报告 大华会计师事务所(特殊普) 北京市海淀区西四环中路 16 号院 7 号楼 12 层 [100039] 电话:86 (10) 5835 0011 传真: 86 (10) ! 募 集 资 金 存 放 与 使 用 情 况 鉴 证 报 告 大华核字[2024]0011002839 ...

法定代表人：袁剑敏 主管会计工作负责人：刘海琴 会计机构负责人：陈丽娟 单位：万元 深圳市华盛昌科技实业股份有限公司 | | | 占用方与上市公 | 上市公司核 | 年期初 2023 | 年度占用累 2023 | 年度占 2023 | 年度偿还 2023 | 年期末占 2023 | 占用形成 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性资金占用 | 资金占用方名称 | | 算的会计科 | | 计发生金额（不含 | 用资金的利 | | | | 占用性质 | | | | 司的关联关系 | 目 | 占用资金余额 | 利息） | 息（如有） | 累计发生金额 | 用资金余额 | 原因 | | | 控股股东、实际控制 | | | | | | | | | | | | 人及其附属企业 | | | | | | | | | | | | 小计 | - | - | - | | | | | | | - | | 前控股股东、实际控 | | | | | | | | | | | | 制人及其附属企业 | | | | | | | ...

Financial Performance - The company's operating revenue for 2023 was CNY 669,847,260.45, representing a 12.24% increase compared to CNY 596,775,379.37 in 2022[16]. - The net profit attributable to shareholders for 2023 was CNY 107,135,761.25, up 9.05% from CNY 98,242,651.87 in the previous year[16]. - The net cash flow from operating activities surged by 244.54% to CNY 179,774,343.22, compared to CNY 52,177,675.36 in 2022[16]. - Basic earnings per share increased by 6.76% to CNY 0.79, compared to CNY 0.74 in 2022[16]. - Total assets at the end of 2023 reached CNY 1,352,557,543.80, a 16.41% increase from CNY 1,161,933,552.44 at the end of 2022[16]. - The net assets attributable to shareholders increased by 3.92% to CNY 1,055,662,851.26, compared to CNY 1,015,841,691.22 at the end of 2022[16]. - The company reported a significant increase in cash generated from operating activities, totaling approximately ¥180 million for the year, with a peak of ¥67.69 million in Q4[21]. - The company achieved a net profit of 107.14 million yuan in 2023, a significant increase compared to the previous year's net profit of 5.22 million yuan, representing a growth of 1,944.44%[117]. - Operating cash flow net amount reached 179.77 million yuan, up 244.54% from 52.18 million yuan in 2022, primarily due to reduced expenditures on goods and services and improved cash management[116]. Revenue Breakdown - The company's total revenue for the year was approximately ¥690 million, with a quarterly breakdown of ¥151.23 million in Q1, ¥175.96 million in Q2, ¥163.48 million in Q3, and ¥179.17 million in Q4[21]. - The net profit attributable to shareholders for the year was approximately ¥107 million, with quarterly figures of ¥21.06 million in Q1, ¥35.55 million in Q2, ¥34.42 million in Q3, and ¥16.11 million in Q4[21]. - The gross profit margin improved by 3.08%, leading to a gross profit increase of 48.66 million yuan, a growth of 21.31%[88]. - The company's overseas business generated sales revenue of 557.5124 million yuan in 2023, an increase of 45.3935 million yuan year-on-year, accounting for 62.93% of the overall sales revenue growth[91]. - The sales revenue of electrical and power measurement products reached 360.6060 million yuan in 2023, an increase of 45.6160 million yuan year-on-year, with a growth rate of 14.48%[92]. - Medical testing products achieved sales revenue of 30.4619 million yuan in 2023, an increase of 14.2628 million yuan year-on-year, representing a growth rate of 88.05%[93]. - The revenue from new energy and related testing grew by 33.79% to ¥38,519,411.32, compared to ¥28,790,454.87 in the previous year[98]. Market and Industry Trends - The global test and measurement instruments market is projected to grow from $34.3 billion in 2023 to $42.9 billion by 2028, representing a compound annual growth rate (CAGR) of 4.6%[28]. - The rapid development of high-end chips and sensors is driving innovation in the test and measurement instruments industry, enhancing measurement sensitivity and accuracy[31]. - The continuous promotion of new infrastructure projects in China has created significant market opportunities for the testing and measurement instrument industry[35]. - The testing and measurement instruments industry is experiencing unprecedented opportunities due to the rapid development of emerging technologies such as 5G and IoT[30]. Research and Development - The company has developed five major technology platforms, enhancing its research and development capabilities with approximately 194 R&D personnel[81]. - The company’s R&D investment increased from 37.30 million yuan in 2019 to 80.95 million yuan in 2023, with a compound annual growth rate of 21.37%[96]. - The company is actively integrating AI technology into its products, improving efficiency and user experience[84]. - The company is focusing on developing new technologies and products in response to the rapid growth of the photovoltaic, new energy vehicle, and charging pile industries[94]. - The company is investing in multiple technology platforms, including semiconductor, sensor, measurement technology, and AI, to ensure product innovation and technical leadership[144]. Product Development and Innovation - The company has developed a range of innovative products for emerging applications, including electric vehicle charging technology and energy storage systems[42]. - The company has launched a third-generation infrared thermal imaging platform that integrates advanced image processing and AI algorithms, reducing costs and complexity[47]. - The company has developed a molecular diagnostic technology utilizing sensor technology for PCR, enabling real-time monitoring and accurate quantification of specific RNA sequences in infectious disease detection[60]. - The company is developing a high-voltage digital insulation meter aimed at enhancing safety and efficiency in power testing, which is currently in the research phase[110]. - The company is focusing on modular design for its products to meet diverse application needs and optimize resource utilization[111]. Governance and Management - The company has established a complete and independent governance structure, including a board of directors and supervisory board[174]. - The company maintains complete independence from its controlling shareholders in terms of assets, personnel, finance, and operations[171]. - The company has a strong management team with members holding advanced degrees and significant experience in finance and engineering[182][184]. - The board of directors held 6 meetings during the reporting period to ensure effective governance and strategic decision-making[165]. - The company has implemented a stock incentive plan with a total of 120 million shares granted to executives, aimed at aligning management interests with shareholder value[179]. Future Outlook - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 25% based on new product launches and market expansion strategies[161]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[161]. - The company aims to enhance brand building through various channels, improving market share and competitiveness[151]. - The company plans to enhance its online presence, aiming for a 30% increase in online sales by the end of 2023[199]. - The company is actively pursuing potential mergers and acquisitions to enhance its market position and diversify its product offerings[179].

关于召开 2023 年年度股东大会的通知 深圳市华盛昌科技实业股份有限公司 1、股东大会届次：2023年年度股东大会。 2、股东大会的召集人：公司董事会。 3、会议召开的合法、合规性：2024年4月18日，公司第三届董事会2024年第 五次会议审议通过了《关于提请召开2023年年度股东大会的议案》。本次股东大 会会议召开符合有关法律、行政法规、部门规章、规范性文件和《公司章程》的 规定。 4、会议召开的日期、时间： 证券代码：002980 证券简称：华盛昌 公告编号：2024-041 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 现场会议召开时间：2024年5月17日（星期五）下午15:00开始（参加现场会 议的股东请于会前15分钟到达开会地点，办理签到手续）； 通过深圳证券交易所交易系统进行网络投票的时间为：2024年5月17日上午 9:15-9:25、9:30-11:30、下午13:00-15:00； 通过深圳证券交易所互联网投票系统（http://wltp.cninfo.com.cn）进行网络投 票的时间为：2024年5月1 ...